Health ❯ Healthcare ❯ Drug Safety

Side Effects

Adverse Reactions Patient Dropout Rates Clinical Study Results Differentiation Syndrome Clinical Trials Patient Tolerance Patient Warnings Clinical Safety Profiles Ocular Issues Hypoglycemia GLP-1 Drugs ARCALYST Safety Information Risks of Tirzepatida Amyloid-Related Imaging Abnormalities Clinical Warnings Clinical Trial Side Effects Gastrointestinal Issues

Sionna Halts SION-719 After Mid-Stage Cystic Fibrosis Trial Misses Key Biomarker

The failed sweat‑chloride readout prompted the program halt, triggering a near‑92% premarket share collapse as the company reviews next steps.

Biogen's Tau Drug Cuts Brain Tau but Misses Dose‑Response Goal

Definium’s Oral LSD Pill Meets Primary Endpoint in Phase 3 Depression Trial

FDA Approves Awiqli, First Once-Weekly Basal Insulin for Type 2 Diabetes

Pfizer’s Monthly Obesity Shot Shows Mid-Stage Gains With Up to 12.3% Weight Loss

FDA Clears Enhertu-Perjeta Combo for First-Line HER2-Positive Metastatic Breast Cancer

Cannabis Extract VER-01 Eases Chronic Low Back Pain in Phase 3 Trial

Pumitamig Shows High Response in First-Line Small Cell Lung Cancer Phase 2